Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC

Bone-metastatic castration-resistant prostate cancer (CRPC) is lethal due to inherent resistance to androgen deprivation therapy, chemotherapy, and targeted therapies. Despite the fact that a majority of CRPC patients (approximately 70%) harbor a constitutively active PI3K survival pathway, targetin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Clin Exp Urol
Päätekijät: Toth, Rachel K, Tran, Jack D, Muldong, Michelle T, Nollet, Eric A, Schulz, Veronique V, Jensen, Corbin C, Hazlehurst, Lori A, Corey, Eva, Durden, Donald, Jamieson, Christina, Miranti, Cindy K, Warfel, Noel A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: e-Century Publishing Corporation 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734039/
https://ncbi.nlm.nih.gov/pubmed/31511835
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia